Benjamin W. Corn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin W. Corn has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Dan Schifter
Radiation Oncology Department, Tel Aviv Souraskiy Medical Center, affiliated with Tel Aviv University School of Medicine, 6 Weizmann St., Tel Aviv, 64239, Israel
4 shared publications Isaiah D. Wexler
Hadassah University Hospital, Hebrew University School of Medicine, Jerusalem, Israel
3 shared publicationsMoshe Inbar
Department of Oncology, Tel Aviv Medical Center and the Tel Aviv University School of Medicine, Tel Aviv, Israel
3 shared publicationsWalter J. Curran
Emory University School of Medicine, 1365 Clifton Rd, NE Atlanta, GA, 30322, USA
3 shared publications- Allen Tannenbaum
Schools of Electrical & Computer Engineering and Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, 30332-0250, U.S.A
2 shared publications - Andrew Ariye Kanner
Department of Neurosurgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2 shared publications
Latest Publications
- 1 July 2017
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 98 (3) , 506-507
Radiation Therapy in the Middle East: Local and Regional Targets
- 1 July 2017
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 98 (3) , 506-507
Radiation Therapy in the Middle East: Local and Regional Targets
- Open Access
- 18 November 2016
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 21 (12) , 1538-1539
Tumor Humor?
A 64-year-old man was referred to me to discuss therapeutic options for his recently diagnosed prostate cancer. His wife told me that “John was paralyzed by the choices.” Because the urologist sent a detailed note along with magnificent MR images, the patient expressed reluctance when I gestured that the time had come to perform a digital rectal examination of his gland. Then, just as my gloved finger anticipated palpation of the nodule, he thunderously farted. “Is this what they mean by being in the cloud?” I asked. Rather than retorting with an I-told-you-so, he craned his neck backward and cheerfully reciprocated: “It just goes to show you that physicians aren’t the only ones who offer sound advice these days.” Approximately 90 minutes later, at the end of the visit, the patient consented to receive a course of external beam irradiation and hormonal therapy under my direction.
- 18 November 2016
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 21 (12) , 1538-1539
Open AccessTumor Humor?
A 64-year-old man was referred to me to discuss therapeutic options for his recently diagnosed prostate cancer. His wife told me that “John was paralyzed by the choices.” Because the urologist sent a detailed note along with magnificent MR images, the patient expressed reluctance when I gestured that the time had come to perform a digital rectal examination of his gland. Then, just as my gloved finger anticipated palpation of the nodule, he thunderously farted. “Is this what they mean by being in the cloud?” I asked. Rather than retorting with an I-told-you-so, he craned his neck backward and cheerfully reciprocated: “It just goes to show you that physicians aren’t the only ones who offer sound advice these days.” Approximately 90 minutes later, at the end of the visit, the patient consented to receive a course of external beam irradiation and hormonal therapy under my direction.
- 10 December 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (35) , 4230
Palliative Care Versus Spiritual Care
- 10 December 2015
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (35) , 4230
Palliative Care Versus Spiritual Care
- 1 December 2014
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 37 (6) , 597-602
Israeli Dying Patient Act
Objectives: The recently enacted Israeli Dying Patient Act was designed to strike balance between enhancing patient autonomy in end-of-life decision making and cultural/religious norms that are in opposition to active euthanasia and physician-assisted suicide (PAS). The current study evaluated physician attitudes regarding active and passive euthanasia, and their knowledge of specific aspects of the law. Methods: A survey was administered to a convenience sample of hospital-based physicians treating terminal patients. Physicians were queried about their attitudes regarding euthanasia and PAS. Physicians were also queried about specific aspects of the law and whether they had sufficient resources to uphold the law. Results: Surveys were distributed to 270 physicians and 100 were returned and evaluated (37%). Nearly all physicians supported passive euthanasia (withholding treatment), whereas over 40% maintained that active forms of euthanasia should be allowed for terminal patients in severe physical pain. Multivariate analysis showed a negative relationship between support for more active forms of euthanasia and physicians’ self-reported religiosity. Physicians cited lack of time as a reason for not complying with the new law. Physicians had a familiarity with the general aspects of the new legislation, but a large proportion was not aware of the specifics of the law. Conclusions: Compared with previous surveys, a larger number of physicians support passive euthanasia. A sizable percentage of physicians would be willing to participate in active euthanasia and even PAS. Attitudes toward euthanasia are influenced by religious factors.
- 1 December 2014
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 37 (6) , 597-602
Israeli Dying Patient Act
Objectives: The recently enacted Israeli Dying Patient Act was designed to strike balance between enhancing patient autonomy in end-of-life decision making and cultural/religious norms that are in opposition to active euthanasia and physician-assisted suicide (PAS). The current study evaluated physician attitudes regarding active and passive euthanasia, and their knowledge of specific aspects of the law. Methods: A survey was administered to a convenience sample of hospital-based physicians treating terminal patients. Physicians were queried about their attitudes regarding euthanasia and PAS. Physicians were also queried about specific aspects of the law and whether they had sufficient resources to uphold the law. Results: Surveys were distributed to 270 physicians and 100 were returned and evaluated (37%). Nearly all physicians supported passive euthanasia (withholding treatment), whereas over 40% maintained that active forms of euthanasia should be allowed for terminal patients in severe physical pain. Multivariate analysis showed a negative relationship between support for more active forms of euthanasia and physicians’ self-reported religiosity. Physicians cited lack of time as a reason for not complying with the new law. Physicians had a familiarity with the general aspects of the new legislation, but a large proportion was not aware of the specifics of the law. Conclusions: Compared with previous surveys, a larger number of physicians support passive euthanasia. A sizable percentage of physicians would be willing to participate in active euthanasia and even PAS. Attitudes toward euthanasia are influenced by religious factors.
- Open Access
- 19 September 2013
- Published by Wiley in The Oncologist
- Vol. 18 (10) , 1144-1146
The Heroic Role of the Caregiver in Oncology: A Photojournalistic Report
- 19 September 2013
- Published by Wiley in The Oncologist
- Vol. 18 (10) , 1144-1146
Open AccessThe Heroic Role of the Caregiver in Oncology: A Photojournalistic Report
- Open Access
- 23 April 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 96
Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study
Rectal toxicity presents a significant limiting factor in prostate radiotherapy regimens. This study evaluated the safety and efficacy of an implantable and biodegradable balloon specifically designed to protect rectal tissue during radiotherapy by increasing the prostate–rectum interspace. Balloons were transperineally implanted, under transrectal ultrasound guidance, into the prostate–rectum interspace in 27 patients with localized prostate cancer scheduled to undergo radiotherapy. Patients underwent two simulations for radiotherapy planning--the first simulation before implant, and the second simulation seven days post implant. The balloon position, the dimensions of the prostate, and the distance between the prostate and rectum were evaluated by CT/US examinations 1 week after the implant, weekly during the radiotherapy period, and at 3 and 6 months post implant. Dose-volume histograms of pre and post implantation were compared. Adverse events were recorded throughout the study period. Four of 27 patients were excluded from the evaluation. One was excluded due to a technical failure during implant, and three patients were excluded because the balloon prematurely deflated. The balloon status was evaluated for the duration of the radiotherapy period in 23 patients. With the balloon implant, the distance between the prostate and rectum increased 10-fold, from a mean 0.22 ± 0.2 cm to 2.47 ± 0.47 cm. During the radiotherapy period the balloon length changed from 4.25 ± 0.49 cm to 3.81 ± 0.84 cm and the balloon height from 1.86 ± 0.24 cm to 1.67 ± 0.22 cm. But the prostate-rectum interspace distance remained constant from beginning to end of radiotherapy: 2.47 ± 0.47 cm and 2.41 ± 0.43 cm, respectively. A significant mean reduction in calculated rectal radiation exposure was achieved. The implant procedure was well tolerated. The adverse events included mild pain at the perineal skin and in the anus. Three patients experienced acute urinary retention which resolved in a few hours following conservative treatment. No infections or thromboembolic events occurred during the implant procedure or during the radiotherapy period. The transperineal implantation of the biodegradable balloon in patients scheduled to receive radiotherapy was safe and achieved a significant and constant gap between the prostate and rectum. This separation resulted in an important reduction in the rectal radiation dose. A prospective study to evaluate the acute and late rectal toxicity is needed.
- 23 April 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 96
Open AccessApplication of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study
Rectal toxicity presents a significant limiting factor in prostate radiotherapy regimens. This study evaluated the safety and efficacy of an implantable and biodegradable balloon specifically designed to protect rectal tissue during radiotherapy by increasing the prostate–rectum interspace. Balloons were transperineally implanted, under transrectal ultrasound guidance, into the prostate–rectum interspace in 27 patients with localized prostate cancer scheduled to undergo radiotherapy. Patients underwent two simulations for radiotherapy planning--the first simulation before implant, and the second simulation seven days post implant. The balloon position, the dimensions of the prostate, and the distance between the prostate and rectum were evaluated by CT/US examinations 1 week after the implant, weekly during the radiotherapy period, and at 3 and 6 months post implant. Dose-volume histograms of pre and post implantation were compared. Adverse events were recorded throughout the study period. Four of 27 patients were excluded from the evaluation. One was excluded due to a technical failure during implant, and three patients were excluded because the balloon prematurely deflated. The balloon status was evaluated for the duration of the radiotherapy period in 23 patients. With the balloon implant, the distance between the prostate and rectum increased 10-fold, from a mean 0.22 ± 0.2 cm to 2.47 ± 0.47 cm. During the radiotherapy period the balloon length changed from 4.25 ± 0.49 cm to 3.81 ± 0.84 cm and the balloon height from 1.86 ± 0.24 cm to 1.67 ± 0.22 cm. But the prostate-rectum interspace distance remained constant from beginning to end of radiotherapy: 2.47 ± 0.47 cm and 2.41 ± 0.43 cm, respectively. A significant mean reduction in calculated rectal radiation exposure was achieved. The implant procedure was well tolerated. The adverse events included mild pain at the perineal skin and in the anus. Three patients experienced acute urinary retention which resolved in a few hours following conservative treatment. No infections or thromboembolic events occurred during the implant procedure or during the radiotherapy period. The transperineal implantation of the biodegradable balloon in patients scheduled to receive radiotherapy was safe and achieved a significant and constant gap between the prostate and rectum. This separation resulted in an important reduction in the rectal radiation dose. A prospective study to evaluate the acute and late rectal toxicity is needed.
- 1 December 2012
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (12) , 1196-1197
Cancer of the heart
- 1 December 2012
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (12) , 1196-1197
Cancer of the heart
- Open Access
- 16 February 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 23
AP-PA field orientation followed by IMRT reduces lung exposure in comparison to conventional 3D conformal and sole IMRT in centrally located lung tumors
Little attention has been paid to the fact that intensity modulated radiation therapy (IMRT) techniques do not easily enable treatment with opposed beams. Three treatment plans (3 D conformal, IMRT, and combined (anterior-posterior-posterio-anterior (AP-PA) + IMRT) of 7 patients with centrally-located lung cancer were compared for exposure of lung, spinal cord and esophagus. Combined IMRT and AP-PA techniques offer better lung tissue sparing compared to plans predicated solely on IMRT for centrally-located lung tumors.
- 16 February 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 23
Open AccessAP-PA field orientation followed by IMRT reduces lung exposure in comparison to conventional 3D conformal and sole IMRT in centrally located lung tumors
Little attention has been paid to the fact that intensity modulated radiation therapy (IMRT) techniques do not easily enable treatment with opposed beams. Three treatment plans (3 D conformal, IMRT, and combined (anterior-posterior-posterio-anterior (AP-PA) + IMRT) of 7 patients with centrally-located lung cancer were compared for exposure of lung, spinal cord and esophagus. Combined IMRT and AP-PA techniques offer better lung tissue sparing compared to plans predicated solely on IMRT for centrally-located lung tumors.
- 1 February 2012
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (2) , 123-124
Medical paternalism: who knows best?
- 1 February 2012
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (2) , 123-124
Medical paternalism: who knows best?
- 1 February 2012
- Published by Elsevier in Medical Image Analysis
- Vol. 16 (2) , 374-385
Multiscale 3D shape representation and segmentation with applications to hippocampal/caudate extraction from brain MRI
- 1 February 2012
- Published by Elsevier in Medical Image Analysis
- Vol. 16 (2) , 374-385
Multiscale 3D shape representation and segmentation with applications to hippocampal/caudate extraction from brain MRI